Methylprednisolone Terminated Phase 3 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00418145Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks